Abbott Laboratories (ABT) Free Cash Flow
Abbott Laboratories (ABT) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $2.08B |
| 2017-12-31 | $4.43B |
| 2018-12-31 | $4.91B |
| 2019-12-31 | $4.50B |
| 2020-12-31 | $5.72B |
| 2021-12-31 | $8.65B |
| 2022-12-31 | $7.80B |
| 2023-12-31 | $5.06B |
| 2024-12-31 | $6.35B |
| 2025-12-31 | $7.39B |
How ABT compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| GILD | Gilead Sciences Inc. | $9.46B |
| PFE | Pfizer Inc. | $9.07B |
| AMGN | Amgen Inc. | $8.10B |
| TMO | Thermo Fisher Scientific Inc | $6.29B |
| MDT | Medtronic plc. | $5.43B |
These are five companies in the same sector as ABT with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Abbott Laboratories Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("ABT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ABT | $101.29 | +0.22% | 7.73M |
| 3 | ||||
| 4 | ||||
| 5 |